Normalization for peak oxygen uptake increases the prognostic power of the ventilatory response to exercise in patients with chronic heart failure

American Heart Journal

Volumn 146, Issue 3, 2003, Pages 542-548

  Guazzi, Marco ^a   De Vita, Stefano ^a   Cardano, Paola ^a   Barlera, Simona ^a   Guazzi, Maurizio D ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON DIOXIDE; OXYGEN;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; CORRELATION ANALYSIS; EXERCISE TEST; FEMALE; FOLLOW UP; HEART FAILURE; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; LUNG DIFFUSION CAPACITY; LUNG FUNCTION TEST; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; PARAMETER; PHYSICAL PERFORMANCE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; SPIROMETRY;

EID: 0042833221     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00321-1     Document Type: Article

References (28)

1. Chua TP, Ponikowski P, Harrington D, et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-90.
2. Robbins M, Francis G, Pashkow FJ, et al. Ventilatory and heart rate response to exercise: better predictors of heart failure mortality than peak oxygen consumption. Circulation 1999;100:2411-7.
3. Kleber FX, Vietzke G, Wernecke KD, et al. Impairment of ventilatory efficiency in heart failure. Circulation 2000;101:2803-9.
4. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001;103:967-72.
5. Sullivan M, Higginbotham M, Cobb F. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite hemodynamic and pulmonary abnormalities. Circulation 1988;77:552-9.
6. Wasserman K, Zangh YY, Gitt A, et al. Lung function and exercise gas exchange in chronic heart failure. Circulation 1997;96:2221-7.
7. Francis DP, Shamin W, Davies LC, et al. Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2) slope and peak VO(2). Eur Heart J 2000;21:154-61.
8. Beaver WL, Wasserman K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020-7.
9. Knudson RJ, Lebowitz MD, Holber CJ, et al. Changes in the normal maximal expiratory flow-volume curve with growth and aging. Am Rev Resp Dis 1983;127:725-34.
10. Roughton FJW, Forster FE. Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in human lung, with special reference to true diffusing capacity of blood in the lung capillary. J Appl Physiol 1957;11:290-302.
11. Kalbfleisch J, Prentics RL. The statistical analysis of heart failure time data. New York: John Wiley Sons; 1980.
12. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
13. Puri S, Baker L, Dutka DP, et al. Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure: its pathophysiological relevance and relationship to exercise performance. Circulation 1995;91:2769-74.
14. Guazzi M, Marenzi GC, Alimento M, et al. Improvement of alveolar membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin. Circulation 1997;95:1930-6.
15. Guazzi M, Pontone G, Brambilla R, et al. Alveolar-capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure. Eur Heart J 2002;23:467-76.
16. Mancini D, Eisen H, Kussmaul W, et al. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 1991;83:778-86.
17. Meyers J, Gullestad L. The role of exercise testing and gas exchange measurements in the prognostic assessment of patients with heart failure. Curr Opin Cardiol 1998;13:145-55.
18. Guazzi M. Exercise testing to monitor heart failure treatment. In: Wasserman K, editor. Cardiopulmonary exercise testing and cardiovascular health. Armonk (NY): Futura Publishing Co Inc; 2002. p. 221-38.
19. Mancini D, Lejemtel T, Aaronson K. Peak VO(2): a simple yet enduring standard. Circulation 2000;101:1152-7.
20. Stelken AM, Jounis LT, Jennison SH, et al. Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy. J Am Coll Cardiol 1996;27:345-52.
21. Osman AF, Mehra MR, Lavie CJ, et al. The incremental prognostic importance of body fat adjusted peak oxygen consumption in chronic heart failure. J Am Coll Cardiol 2000;36:21-6.
22. Johnson RL Jr. Gas exchange efficiency in congestive heart failure II. Circulation 2001;103:916-8.
23. Ponikowski PP, Chua TP, Francis DP, et al. Muscle ergoreceptor overactivity reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. Circulation 2001;104:2324-30.
24. Chua TP, Clark AL, Amadi AA, et al. The relationship between chemosensitivity and the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996;27:650-7.
25. Piepoli M, Clark AM, Volterrani M, et al. Contribution of muscle afferents to the hemodynamic, autonomic and ventilatory responses to exercise in patients with chronic heart failure. Circulation 1996;93:940-52.
26. Chua TP, Harrington D, Ponikowski P, et al. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997;29:147-52.
27. Arena R, Humphrey R. Comparison of ventilatory expired gas parameters used to predict hospitalisation in patients with heart failure. Am Heart J 2002;143:427-32.
28. Narkiewikcz K, Pesek CA, van de Borne PJ, et al. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999;100:262-7.